Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections
Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections
NCT ID: NCT04579640 Phase: PHASE3 Status: COMPLETED Enrollment: 6200 Completion: 2022-02-28
Conditions
Covid19, Acute Respiratory Tract Infection
Interventions
Vitamin D
Summary
CORONAVIT is an open-label, phase 3, randomised clinical trial testing whether implementation of a test-and-treat approach to correction of sub-optimal vitamin D status results in reduced risk and/or severity of COVID-19 and other acute respiratory infections.
Primary Outcome
Proportion of participants experiencing at least one doctor-diagnosed or laboratory-confirmed acute respiratory infection of any cause.